Acquisition of minority interests

4D pharma plc

(the 'Company' or '4D')

Acquisition of minority interests

4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of live biotherapeutics, is pleased to confirm that it has acquired the remaining minority interests in GT Biologics Limited, amounting, in aggregate, to approximately 16.5% of its issued share capital, which is now wholly owned and has been renamed 4D pharma Research Limited.

For further information please contact: